Isabelle Ray-Coquard, Medical Oncologist at Léon Bérard Center, shared a post on LinkedIn, about a paper by her and colleagues, published in Annals of Oncology:
“Paola-1 publications, new episode in Annals of Oncology 2024 revealing that subsequent therapies can be impacted differently after 1st line maintenance with parpi and bevacizumab or bevacizumab alone…
Very proud to share this academic international collaborative new publication from ENGOTov25 Paola-1 study.”
Authors: P. Harter, C. Marth, M. Mouret-Reynier, E. Pujade-Lauraine, I. Ray-Coquard et al.
More posts featuring Isabelle Ray-Coquard.
